Skip to Main Content

Paper Details

Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancer.
NPJ Breast Cancer
38
2022
Author NameAffiliation
Massimo Cristofanilli
Giuseppe CuriglianoEuropean Institute of Oncology, IRCCS and University of Milano
  • 1 - 2

Datasets

Release 1.2